Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04191733 · ClinicalTrials.gov registry record · NA
Anterior Advantage With KINCISE
A NA study, sponsored by DePuy Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT04191733 is a NA study that was terminated before completion, run by DePuy Orthopaedics. The registered enrollment target is 250 participants.
The verdict
NCT04191733, a NA study, was terminated before completion, sponsored by DePuy Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.
Interventions
- DEVICE KINCISE(TM) Surgical Automated System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-01-28 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04191733
The ClinicalTrials.gov registry entry for NCT04191733 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KINCISE(TM) Surgical Automated System is the first listed.
NCT04191733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04191733 about?
NCT04191733 is a clinical study titled "Anterior Advantage With KINCISE". This is a post-market prospective, 1:1 randomized, multicenter non-inferiority study to compare the femoral broaching time for THA with the Anterior Advantage approach with KINCISE vs. without KINCISE. Follow-up will continue through 24 weeks post-op.
What is the current status of trial NCT04191733?
This trial is currently terminated. It is a NA study. The enrollment target is 250 participants. The study started on 2020-01-28. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04191733?
The interventions under investigation include: KINCISE(TM) Surgical Automated System (DEVICE).
Who is sponsoring clinical trial NCT04191733?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.